Skip to the page

Data / Form D filings / CardioWise, Inc.

CardioWise, Inc.: Form D filings

CardioWise, Inc., a biotechnology company in Fayetteville, AR, filed 8 Form D notices with the SEC between 2012 and 2025. The latest, on September 8, 2025, reports an offering of $3 million with nothing sold yet.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
535 W. RESEARCH CENTER BOULEVARD, SUITE 135, Fayetteville, AR, 72701
Phone
(479) 571-2592
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1560519

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 8, 2025New notice$3,000,000$0$3,000,0000Yet to occursec.gov
Mar 11, 2022New notice$1,000,000$300,000$700,0003Nov 29, 2021sec.gov
Mar 26, 2020New notice$1,000,000$340,000$660,0002Mar 5, 2020sec.gov
Sep 14, 2018New notice$357,192$357,1924Feb 1, 2018sec.gov
Feb 28, 2017New notice$700,000$225,000$475,0003Feb 16, 2017sec.gov
Nov 24, 2015Amendment$2,000,000$620,000$1,380,0009Mar 13, 2014sec.gov
Mar 17, 2014New notice$2,000,000$25,000$1,975,0001Mar 13, 2014sec.gov
Oct 17, 2012New notice$600,000$50,000$550,0001Oct 3, 2012sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
John CoatsExecutive Officer

Every Form D from the week of Sep 8, 2025 · All recent filings in Arkansas · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what CardioWise, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.